(Scientific research) is…a voyage of discovery into unknown lands, seeking not for new territory but for new knowledge, it should appeal to those with a good sense of adventure                                   Frederick Sanger

Human Genetic Signatures (HGS) is a privately held Biotech company located in Sydney, Australia. It is positioned in the Molecular Diagnostics marketplace and enjoys a rich portfolio of IP, know-how and development projects relating to clinical diagnostics, methylation, cancer detection and alternative molecular detection methods.

“Simplification” Technology

Take a New Look at Microbial Detection

HGS has developed revolutionary Simplification technology designed to simplify the molecular detection of micro-organisms. It aims to partner with Diagnostics Companies having a platform which can assimilate the simplification method and obtain benefit from the development of molecular diagnostics to detect specific microbial targets such as HPV, HCV, HIV, MRSA, CT/NG and TB.

more...

MethylEasy™ Kits

MethylEasy™ Methylation Detection Range

We are also the inventors of the MethylEasy™ methodology used worldwide for analysing chemical changes that occur in DNA in cancer, aging, stem cells and cell reprogramming. We market world-leading MethylEasy™ products that facilitate these DNA Methylation analyses for research scientists. This includes MethylEasy™ (25 reactions), MethylEasy™High-throughput for centrifuge and vacuum and MethylEasy™ “Xceed – our latest, fastest and most sensitive protocol to date. more...